Application | Comment | Organism |
---|---|---|
medicine | the inhibitors (-)-epigallocatechin gallate, (-)-epicatechin gallate and (+)-gallocatechin are expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(+)-gallocatechin | IC50: 0.000109 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica | |
(-)-epicatechin gallate | IC50: 10.2 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica | |
(-)-epigallocatechin gallate | IC50: 0.000142 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Elizabethkingia meningoseptica | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyloxycarbonyl-Gly-Pro-p-nitroanilide + H2O | - |
Elizabethkingia meningoseptica | benzyloxycarbonyl-Gly-Pro + p-nitroaniline | - |
? |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000109 | - |
IC50: 0.000109 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica | (+)-gallocatechin | |
0.000142 | - |
IC50: 0.000142 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica | (-)-epigallocatechin gallate | |
10.2 | - |
IC50: 10.2 mM, expected to be useful for preventing and curing of Alzheimers disease | Elizabethkingia meningoseptica | (-)-epicatechin gallate |